ACW — Actinogen Medical Cashflow Statement
0.000.00%
Last trade - 00:00- AU$85.78m
- AU$72.54m
- AU$0.69m
Annual cashflow statement for Actinogen Medical, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | -0.415 | -6.53 | -4.14 | -11.2 | -1.42 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -1.72 | -9.52 | -8.7 | -17 | -7.56 |
| Capital Expenditures | -0.006 | -0.003 | -0.037 | -0.008 | -0.038 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -0.006 | -0.003 | -0.037 | -0.008 | -0.038 |
| Financing Cash Flow Items | -0.716 | -0.831 | 0 | -1.06 | -0.53 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 10.1 | 12.4 | 0.825 | 17.9 | 14.6 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 8.38 | 2.91 | -7.91 | 0.991 | 7.05 |